Faron Pharmaceuticals Oy 13 December 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron's Financial Calendar for 2025 Company announcement, 13 December 2024 TURKU...
cals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive ph ...
Faron presents BEXMAB data at ASH Annual Meeting PR Newswire TURKU, Finland, Dec. 10, 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Presents Full Analysis of Positive Phase 2...
Faron Pharmaceuticals Ltd on Wednesday reported positive data from an ongoing trial on patients receiving a new treat ...
Faron Pharmaceuticals Oy 27 November 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Inside Information: Faron Announces Positive Phase 2 Interim Results from BEXMAB Trial to...
Faron Pharmaceuticals Oy 05 November 2024 ("Faron" or "the Company") Composition of Faron Pharmaceutical's Shareholders' Nomination Board Company Announcement, 5 November 2024 TURKU...
Faron Pharmaceuticals Oy 22 October 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron's Capital Markets Day 2024 - BEXMAB follow-up data and update on drug development...
Faron Pharmaceuticals Oy 30 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Grant of options Company announcement, August 30, 2024 TURKU, FINLAND - Faron...
Faron Pharmaceuticals Ltd on Tuesday said its loss widened in the first half of 2024, as the company successfully adv ...
Faron Pharmaceuticals Oy 27 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Reports Half-Year Financial Results, 1 January - 30 June 2024 Company Announcement...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 170 | 175 | 165 | 9705 | 167.79361154 | DE |
4 | 17.5 | 11.4754098361 | 152.5 | 195 | 152.5 | 24951 | 174.47419283 | DE |
12 | -58 | -25.4385964912 | 228 | 228 | 142.5 | 18675 | 176.95842313 | DE |
26 | 71.5 | 72.5888324873 | 98.5 | 233 | 92.5 | 37723 | 159.0438979 | DE |
52 | -130 | -43.3333333333 | 300 | 324 | 89 | 38986 | 150.20935589 | DE |
156 | -105 | -38.1818181818 | 275 | 392.5 | 89 | 21485 | 195.74772987 | DE |
260 | -110 | -39.2857142857 | 280 | 560 | 89 | 32034 | 293.33515398 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約